Safety monitoring of drugs receiving pediatric marketing exclusivity.

MLA

Smith, P.Brian, et al. “Safety Monitoring of Drugs Receiving Pediatric Marketing Exclusivity.” Pediatrics, vol. 122, no. 3, Sept. 2008, pp. e628–33. EBSCOhost, https://doi.org/10.1542/peds.2008-0585.

APA

Smith, P. B., Benjamin, D. K., Jr, Murphy, M. D., Johann-Liang, R., Iyasu, S., Gould, B., Califf, R. M., Li, J. S., & Rodriguez, W. (2008). Safety monitoring of drugs receiving pediatric marketing exclusivity. Pediatrics, 122(3), e628–e633. https://doi.org/10.1542/peds.2008-0585

Chicago

Smith, P Brian, Daniel K Benjamin Jr, M Dianne Murphy, Rosemary Johann-Liang, Solomon Iyasu, Barbara Gould, Robert M Califf, Jennifer S Li, and William Rodriguez. 2008. “Safety Monitoring of Drugs Receiving Pediatric Marketing Exclusivity.” Pediatrics 122 (3): e628–33. doi:10.1542/peds.2008-0585.